Harvey Pass

SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.

Introduction: The SKYSCRAPER-05 (NCT04832854), a phase 2, open-label, multicenter study, evaluated perioperative treatment with tiragolumab plus atezolizumab ± platinum-based chemotherapy in treatment-naive patients with resectable, stage II-IIIB NSCLC. Methods: Cohort A (program...